Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma.
about
Mechanisms of drug resistance in colon cancer and its therapeutic strategiesShort-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis: Efficacy of 7 targeted therapies for AHCC.Dalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating β-catenin degradation in hepatocellular carcinoma cells.Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation.β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer developmentOptimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions.Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
P2860
Q26738528-72002EBD-BCBC-4A9A-9EA0-315B30945D75Q30240170-8153B5BC-B65C-4A9D-985F-50012258A30CQ36382856-00C01C61-24AD-4A11-9445-5896B3F321DAQ37354173-F093E7B8-979C-464E-B5D7-5A4EAE7F57DEQ42683902-C89809E2-C813-4B5F-A09F-AC7CC2051014Q47108754-F067ABD4-8058-4ABF-8D9E-FDD465E56A2CQ58760425-8A4B04A5-6780-4D0B-A56D-6595695764E6
P2860
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase II trial of bevacizumab ...... nced hepatocellular carcinoma.
@ast
Phase II trial of bevacizumab ...... nced hepatocellular carcinoma.
@en
type
label
Phase II trial of bevacizumab ...... nced hepatocellular carcinoma.
@ast
Phase II trial of bevacizumab ...... nced hepatocellular carcinoma.
@en
prefLabel
Phase II trial of bevacizumab ...... nced hepatocellular carcinoma.
@ast
Phase II trial of bevacizumab ...... nced hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Phase II trial of bevacizumab ...... nced hepatocellular carcinoma.
@en
P2093
Ahmed O Kaseb
Ahmed S Shalaby
Hesham M Hassabo
Humaid O Al-Shamsi
James C Yao
Jeffrey S Morris
Kanwal Pratap Singh Raghav
Khaled M Elsayes
Lauren Girard
Lianchun Xiao
P2860
P304
P356
10.2147/OTT.S91977
P407
P577
2016-02-15T00:00:00Z